OKYO
OKYO PHARMA (OKYO)
NASDAQ
$1.54$0.00 (0.00%)
Price as of Aug 21, 2026 7:30 PM EDT
  • $52.1M
    Market Cap
  • -35.02%
    1-Year Change
  • Biotechnology
    Industry
Annual
Quarterly
03/31/2026
03/31/2025
03/31/2024
03/31/2023
Income Statement
Total Operating Revenue
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cost of Revenue
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Gross Profit
0
N/A
0
N/A
0
N/A
0
N/A
Sales and Marketing Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Research and Development Expense
-1.8M
-19.75%
-2.3M
-72.65%
-8.2M
+30.07%
-6.3M
+387.07%
Depreciation and Amortization Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Operating Expenses
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Operating Profit
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Interest Income
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Interest Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Interest Income and Expense and Net
0
N/A
0
N/A
0
N/A
0
N/A
Total Nonoperating Income and Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Income before Taxes
N/A
N/A
N/A
N/A
-16.8M
+26.78%
-13.3M
+144.37%
Income Taxes
-7,987
-100.24%
3.3M
+14,660.04%
-22,416
-283.71%
12,202
-98.45%
Extraordinary Items
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Net Income
N/A
N/A
N/A
N/A
-16.8M
+26.78%
-13.3M
+144.37%
Net Income from Continuing Operations Applicable to Common
N/A
N/A
N/A
N/A
-16.8M
+26.78%
-13.3M
+144.37%
Basic EPS and Net Income
-0.24
+20.00%
-0.20
-64.91%
-0.57
-6.56%
-0.61
N/A
Diluted EPS and Net Income
-0.24
+20.00%
-0.20
-64.91%
-0.57
-6.56%
-0.61
N/A
Basic Weighted Average Shares
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Diluted Weighted Average Shares
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Balance Sheet
Cash and Cash Equivalents
14.6M
+217.27%
4.6M
+456.33%
826,848
-79.56%
4.0M
+49.79%
Short-Term Investments
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
14.6M
+217.27%
4.6M
+456.33%
826,848
-79.56%
4.0M
+49.79%
Total Current Assets
21.0M
+470.57%
3.7M
+138.98%
1.5M
-70.41%
5.2M
+20.98%
Accumulated Depreciation
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Property and Plant and Equipment and Net
N/A
N/A
2,035
-39.25%
3,350
-53.58%
7,216
+38.11%
Total Long-Term Assets
6,311
+210.12%
2,035
-39.25%
3,350
-53.58%
7,216
+38.11%
Total Assets
21.0M
+470.42%
3.7M
+138.59%
1.5M
-70.38%
5.2M
+21.00%
Income Taxes Payable
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Short-Term Debt
2.0M
-25.93%
2.7M
+35.00%
2.0M
+309.83%
488,009
N/A
Total Current Liabilities
8.6M
-6.35%
9.2M
+24.34%
7.4M
+2.26%
7.3M
+436.30%
Total Long-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Long-Term Liabilities
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Liabilities
8.6M
-6.35%
9.2M
+24.34%
7.4M
+2.26%
7.3M
+436.30%
Retained Earnings
-152.0M
+6.26%
-143.0M
+0.35%
-142.5M
+13.39%
-125.7M
+11.80%
Total Stockholders Equity
N/A
N/A
-5.5M
-5.61%
-5.9M
+186.36%
-2.1M
-169.66%
Total Shares Outstanding
52.5M
+45.69%
36.0M
-45.97%
66.7M
-95.98%
1.7B
+20.69%
Cash Flow
Cash from Operating Activities
-5.9M
+227.78%
-1.8M
-80.92%
-9.5M
+23.33%
-7.7M
+40.73%
Capital Expenditures
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Investing Activities
-6.0M
+497,092.05%
-1,208
N/A
N/A
N/A
-5,916
+254.46%
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
25.0M
+842.24%
2.7M
-57.22%
6.2M
-33.41%
9.3M
+332.99%
Financials Ratio
Gross Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Operating Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Return on Assets
N/A
N/A
N/A
N/A
-498.89%
+78.64%
-279.27%
N/A
Return on Equity
N/A
N/A
N/A
N/A
424.20%
+114.29%
-2,968.51%
N/A
Revenue Growth
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Current Ratio
2.43
+509.29%
0.40
+92.23%
0.21
-71.07%
0.72
N/A
Cash Ratio
1.69
+238.80%
0.50
+347.49%
0.11
-80.01%
0.56
N/A
Debt-to-Equity Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Debt-to-Assets Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow